Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220470 Methods for the purification of stable radioiodine conjugates
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220362 Novel inhibitors of formation of advanced glycation endproducts (AGEs)
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220288 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
11/27/2003US20030220287 Inhibit expression of anthrax toxin receptor mRNA and human tumor endothelial marker 8
11/27/2003US20030220286 Undetectable biological effect in the absence of an inducer, but which exhibits efficient inducibility in the presence of an inducer.
11/27/2003US20030220285 Expression vectors for stimulating an immune response and methods of using the same
11/27/2003US20030220282 Antisense modulation of PTP1B expression
11/27/2003US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments.
11/27/2003US20030220274 Plasmid comprising a chicken beta actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (p beta GLP1), carrying a furin cleavage site
11/27/2003US20030220273 Antisense modulation of phosphodiesterase 4D expression
11/27/2003US20030220269 Bile secretagogues
11/27/2003US20030220267 Especially HIV-1 protease inhibitors; peptides containing one or more B-OH groups
11/27/2003US20030220266 Administering an inhibitor of cyclooxygenase-1 and/or an EP2 and/or EP4 receptor antagonist to treat cervical cancer
11/27/2003US20030220265 Dihydroxypropyl cysteine peptide and agent containing this peptide
11/27/2003US20030220263 Treating, diagnosing, preventing, and screening for disorders associated with aberrant cell growth, neurological conditions, and diseases or disorders related to the brain
11/27/2003US20030220262 Prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of vascular endothelial cell growth factor
11/27/2003US20030220261 Administering a gene-regulatory peptide or functional analogue thereof that modulates (especially inhibits) translocation and/or activity of a gene transcription factor such as an NF-kappa B/Rel protein.
11/27/2003US20030220260 Gene-regulatory peptide that modulates translocation or activity of a gene transcription factor, such as an NF-kappaB/Rel protein.
11/27/2003US20030220259 Treatment of neurological disorders
11/27/2003US20030220258 Treatment of ischemic events
11/27/2003US20030220257 Administering a gene-regulatory peptide or functional analogue thereof modulate or treat an immunosuppressive state; modulating activity of a gene transcription factor such as an NF-kappa B/Rel protein.
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220255 GLP-1 agonist and cardiovascular complications
11/27/2003US20030220253 Members of the family of proteins bearing a collagen-like domain and a globular domain. The inhibitors are useful for promoting blood flow in vasculature by reducing thrombogenic and complement activity
11/27/2003US20030220252 Administering to a cancer patient a Luteinizing hormone releasing hormone analog and a cyclic guanosin 3,5-monophosphate-specific phosphodiesterase inhibitor to treat the cancer
11/27/2003US20030220251 Inhibition of beta cell degeneration
11/27/2003US20030220250 Angiopoietin-1 in the treatment of disease
11/27/2003US20030220249 Genes, related nucleic acids, their complements, polypeptides
11/27/2003US20030220248 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
11/27/2003US20030220247 Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factors
11/27/2003US20030220246 Novel FGF homolog zFGF11
11/27/2003US20030220244 Contacting a culture of an adult stem cells with a hedgehog polypeptide to promote the growth and differentiation of a three dimensional cartilage matrix in the culture cells, isolating and transplanting the cartilage matrix to a patient
11/27/2003US20030220243 A 37 amino acid peptide that is secreted by the L-cells of the intestine in response to food ingestion, because of their ability to stimulate insulin secretion, can be used for the treatment of diabetes, obesity and releated conditions
11/27/2003US20030220242 Aqueous prolonged release formulation
11/27/2003US20030220241 Method of treating cancer
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220237 Pharmaceutical composition
11/27/2003US20030220236 Acyl derivatives of the echinocandin class of cyclic peptide; parasiticide
11/27/2003US20030220235 Muteins of the CGRP 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
11/27/2003US20030220234 A cyclosporine A derivative with isotopic or chemical substitution in the amino acid position selected from the group consisting of 1,3, and 9 or combination
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220231 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
11/27/2003US20030220230 Enhancement of iron chelation therapy
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030220226 Compounds and compositions for delivering active agents
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003US20030219886 Directed evolution of novel binding proteins
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219864 Novel variants of RANKL protein
11/27/2003US20030219863 Soluble CTLA4 mutant molecules and uses thereof
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219858 Novel heteromultimeric ion channel receptor and uses thereof
11/27/2003US20030219857 Preparing protein cross-linking enzymes for use in food processing and drug delivevry
11/27/2003US20030219853 Method of cross-linking a compound
11/27/2003US20030219852 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions
11/27/2003US20030219834 Identifying modulator of cold sensation and pain; drug screening; cancer diagnosis
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219823 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/27/2003US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
11/27/2003US20030219794 Comprises nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219786 Novel glycoproteins and methods of use thereof
11/27/2003US20030219777 Comprises expression vector coding sequences for detecting gene position of atherosclerosis susceptibility gene and for modulating cholesterol phenotypes in cells
11/27/2003US20030219774 Comprises nucleotide sequences coding g-protein coupled receptors for treating pain, nervous system, psychological, circadian rhythm, hypotensive, hypertensive and eating disorders
11/27/2003US20030219768 Lung cancer therapeutics and diagnostics
11/27/2003US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders
11/27/2003US20030219748 Regulated prostate cancer genes
11/27/2003US20030219747 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/27/2003US20030219743 Comprises nucleotide sequences for detecting protein factors; forensics; genetic mapping; evaluating biodiversity
11/27/2003US20030219742 Antisense modulation of HMGI-C expression
11/27/2003US20030219740 DNA sequences isolated from human colonic epithelial cells
11/27/2003US20030219728 Comprises nucleotide sequences coding HIV-associated life preserver (HALP) protein for treating apoptosis disorders; viricides; antiapoptosis; genetic vaccines
11/27/2003US20030219722 Comprises preparation of novel binding prolypeptides via mutagenesis, expression, chromatographic selection and amplification; drug screening
11/27/2003US20030219492 Topically applying an effective amount of a formulation containing egg white protein directly onto an amniotic fluid sac of a mammal for sealing a ruptured amniotic membrane
11/27/2003US20030219491 Compositions for inhibiting tumor growth and methods thereof
11/27/2003US20030219486 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker
11/27/2003US20030219474 A polynucleotide that hybridizes to a Bcl-2-encoding polynucleotide and a lipid associated with such polynuclotide
11/27/2003US20030219473 A lipid based cochelate formed of a purified soy- based phospholipid such as soy phosphatidylserine, and a multivalent cation selected from calcium, magnesium and zinc
11/27/2003US20030219472 Compositions and method for transmucosal drug delivery and cryoprotection
11/27/2003US20030219462 Clostridial neurotoxin compositions and modified clostridial neurotoxins
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219451 Stable helical C peptides and uses therefor
11/27/2003US20030219447 Biologically active peptides
11/27/2003US20030219446 Ligand for CD28 receptor on B cells and methods
11/27/2003US20030219444 Genes and encoded polypeptides expressed in cancer cells, used for diagnosis, prophylaxis and as targets of tumors; vaccines
11/27/2003US20030219441 Combined methods and compositions for coagulation and tumor treatment
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219436 Immobilized and soluble forms of CD antigens used for immunology modulation, prophylaxis of inflammation, autoimmune diseases, graft versus host disease and cancer
11/27/2003US20030219434 Antibodies for cancer therapy and diagnosis
11/27/2003US20030219431 Treatment of neuronal and neurological damage associated with spinal cord injury
1 ... 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 ... 3163